Cochrane · systematic review · CD006536
Stem cell treatment for acute myocardial infarction
Fisher, SA, Zhang, H, Doree, C, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
6
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 6 · 100%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Show all 3 versionsCells compared to no cells for acute myocardial infarction (AMI)
Population: patients with AMI
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
All‐cause mortality ‐ short‐term Cells vs no cells | RR 0.8 [0.43, 1.49] | 17 studies · 1365 participants | Moderate Downgraded: imprecision |
All‐cause mortality ‐ long‐term Cells vs no cells | RR 0.93 [0.58, 1.5] | 14 studies · 996 participants | Moderate Downgraded: imprecision |
Cardiovascular mortality ‐ short‐term Cells vs no cells | RR 0.72 [0.28, 1.82] | 7 studies · 290 participants | Moderate Downgraded: imprecision |
Cardiovascular mortality ‐ long‐term Cells vs no cells | RR 1.04 [0.54, 1.99] | 9 studies · 527 participants | Moderate Downgraded: imprecision |
Composite death, reinfarction and hospitalisation for heart failure ‐ short‐term Cells vs no cells | RR 0.36 [0.12, 1.14] | 3 studies · 379 participants | Moderate Downgraded: imprecision |
Composite death, reinfarction and hospitalisation for heart failure ‐ long‐term Cells vs no cells | RR 0.63 [0.36, 1.1] | 6 studies · 497 participants | Moderate Downgraded: imprecision |